Enhanced Monofocal Intraocular Lenses: A Retrospective, Comparative Study between Three Different Models.
cataract
cataract surgery
enhanced monofocal
enhanced monofocal iol
intraocular lens
monofocal IOL
monofocal intraocular lens
presbyopia
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 May 2023
21 May 2023
Historique:
received:
10
04
2023
revised:
16
05
2023
accepted:
19
05
2023
medline:
27
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
The purpose of this study was to compare the visual performance and optical quality between three new enhanced monofocal intraocular lenses (IOLs). This retrospective study included patients affected by cataracts with corneal astigmatism less than 0.75 D and no ocular comorbidities who underwent cataract surgery with bilateral implantation of Tecnis Eyhance ICB00 (Johnson & Johnson Vision Care, Inc., Jacksonville, FL, USA), Vivinex Impress XY1-EM (Hoya Surgical Optics, Singapore) or IsoPure 123 (PhysIOL, Liege, Belgium) IOLs. Three months postoperatively, monocular and binocular uncorrected and corrected distant, and intermediate and near visual acuities were measured. Binocular defocus curve, photopic contrast sensitivity, Point Spread Function (PSF), low order aberrations (LOAs), high order aberrations (HOAs), objective scatter index (OSI), halo and glare perception were also evaluated. This study included a total of 72 eyes from 36 patients. Visual acuity outcomes, PSF, LOAs, HOAs and OSI were similar between groups. There were no statistically significant differences in terms of photopic contrast sensitivity, halo or glare perception. In patients without ocular comorbidities, the Eyhance ICB00 IOL, the Vivinex Impress IOL and the Isopure IOL-even though based on different optical properties-provided similar results in terms of visual acuity, contrast sensitivity and intraocular aberrations, with no influence on photic phenomena.
Identifiants
pubmed: 37240694
pii: jcm12103588
doi: 10.3390/jcm12103588
pmc: PMC10219279
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur J Ophthalmol. 2023 Feb 5;:11206721231154818
pubmed: 36740911
J Ophthalmol. 2022 Jul 7;2022:4119698
pubmed: 35847352
J Cataract Refract Surg. 2021 Feb 1;47(2):184-191
pubmed: 32932369
Am J Ophthalmol. 2019 Dec;208:305-312
pubmed: 30905724
J Cataract Refract Surg. 2016 Feb;42(2):310-28
pubmed: 27026457
Ophthalmology. 2018 Feb;125(2):169-178
pubmed: 28951074
Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3617-3625
pubmed: 35622140
BMC Ophthalmol. 2023 Mar 14;23(1):101
pubmed: 36918799
J Refract Surg. 2022 Jan;38(1):10-20
pubmed: 35020542
J Refract Surg. 2022 Aug;38(8):538-546
pubmed: 35947003
J Cataract Refract Surg. 2020 Mar;46(3):378-387
pubmed: 32050218
Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):194-202
pubmed: 32511121
Clin Ophthalmol. 2023 Mar 25;17:981-990
pubmed: 37007049
J Cataract Refract Surg. 2020 Jun;46(6):902-906
pubmed: 32304487
J Refract Surg. 2023 Mar;39(3):150-157
pubmed: 36892241
J Refract Surg. 2022 Aug;38(8):497-501
pubmed: 35947002
PLoS One. 2011 Feb 04;6(2):e16823
pubmed: 21326868
Optom Vis Sci. 2013 Apr;90(4):392-9
pubmed: 23422945